| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/02/2003 | EP1322411A1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 07/02/2003 | EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 07/02/2003 | EP1322332A2 Compositions and methods for inhibition of hiv-1 infection |
| 07/02/2003 | EP1322324A2 Methods for treating muscle injuries |
| 07/02/2003 | EP1322323A1 Thionin as an antineoplastic and immunostimulant |
| 07/02/2003 | EP1322322A2 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 07/02/2003 | EP1322321A2 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours |
| 07/02/2003 | EP1322320A1 Perilipin as a target for regulation of body weight, muscle mass and diabetes |
| 07/02/2003 | EP1322319A1 Use of il-8 protein modulators in the treatment of viral infections |
| 07/02/2003 | EP1322317A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 07/02/2003 | EP1322296A1 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 07/02/2003 | EP1322291A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 07/02/2003 | EP1322290A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 07/02/2003 | EP1322288A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 07/02/2003 | EP1322287A2 Microparticles for delivery of the heterologous nucleic acids |
| 07/02/2003 | EP1322286A2 Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/02/2003 | EP1150666A4 Stimulating neutrophil function to treat inflammatory bowel disease |
| 07/02/2003 | EP1143994B1 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto)immune diseases |
| 07/02/2003 | EP0954292B1 Pharmaceutical formulations with delayed drug release |
| 07/02/2003 | EP0910246A4 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents |
| 07/02/2003 | EP0873491B1 Ceramic packing with channels for thermal and catalytic beds |
| 07/02/2003 | EP0826043B1 Methods for modulating t cell survival by modulating bcl-xl protein level |
| 07/02/2003 | EP0801557B1 Liposome formulations of 5beta steroids |
| 07/02/2003 | EP0758248B1 Formulations for factor ix |
| 07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 07/02/2003 | CN1427891A Anti-EGFRvIII scFv with improved cytotoxi city and yield, immunotoxins based thereon, and methods of use thereof |
| 07/02/2003 | CN1427889A Hybrid cells obtainable from antigen presenting cells |
| 07/02/2003 | CN1427887A Pluripotent cells comprising allogenic nucleus and mitochondria |
| 07/02/2003 | CN1427839A Charged compounds comprising nucleic acid binding moiety and uses therefor |
| 07/02/2003 | CN1427730A Medicinal aerosol formulation |
| 07/02/2003 | CN1427726A Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 07/02/2003 | CN1427725A Casein derived peptides and uses thereof in therapy |
| 07/02/2003 | CN1427722A Method for treatment or prevention of flavivirus infections using nucleoside analogues |
| 07/02/2003 | CN1427717A Hydrophilic/lipophilic polymeric matrix dosage for mulation |
| 07/02/2003 | CN1427012A Recombination human thymus peptide beta 4Y and its preparation method and use |
| 07/02/2003 | CN1427011A Hemopoiesis factor and its application |
| 07/02/2003 | CN1427010A Preparation method of cholera toxin B sub unit |
| 07/02/2003 | CN1426813A Recombination human epidermis growth factor spraying agent and its preparation method |
| 07/02/2003 | CN1113102C Antitumer preparation |
| 07/02/2003 | CN1113067C New active peptide and production thereof |
| 07/02/2003 | CN1113066C Peptide derivatives |
| 07/02/2003 | CN1112933C Anti-fungal methods and materials |
| 07/02/2003 | CN1112930C P1, P4-dithio-P2,P3-monochloromethylene 5'5-diadenosine P4,P4-tetraphosphate as antithrombotic agent |
| 07/02/2003 | CN1112920C Aminotetralin derivative for therapy of cardiovascular diseases |
| 07/01/2003 | US6586630 Carbocyclic carboxy amines, used as motilin receptor antagonists for therapy of gastrointerstinal disorders such as irritable bowel syndrome; hormone inhibitors |
| 07/01/2003 | US6586602 CD antigen antagonists such as N-(methanesulfonyl)-L-prolyl-L-phenylalanine and prodrugs used as antiinflammatory agents |
| 07/01/2003 | US6586582 Human GABA receptor proteins and polynucleotides encoding the same |
| 07/01/2003 | US6586581 Prolactin regulatory element binding protein and uses thereof |
| 07/01/2003 | US6586580 Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| 07/01/2003 | US6586578 Deformylase (def1); isolated polynucleotide of given sequence; detects Staphylococcus aureus; can use to screen for antibiotics |
| 07/01/2003 | US6586577 Nucleotide sequences coding veterbrate telomere binding protein for use in the treatment of cancer and aging |
| 07/01/2003 | US6586573 Comprising a bulking agent, stabilizing agents, sodium chloride and a buffering agent; decreased risk of transmitting a virus; used in treating hemophilia |
| 07/01/2003 | US6586572 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/01/2003 | US6586571 Isolated polypeptide that binds to MORT-1 (mediators of receptor toxicity) protein |
| 07/01/2003 | US6586570 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/01/2003 | US6586569 Endometriosis-associated gene |
| 07/01/2003 | US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders |
| 07/01/2003 | US6586426 Pyrrolizine derivatives; thrombin, elastase, and factor X inhibitors |
| 07/01/2003 | US6586424 Anticancer agents; anticholesterol agents |
| 07/01/2003 | US6586423 Tyrosine kinase inhibitors |
| 07/01/2003 | US6586406 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 07/01/2003 | US6586405 Non-covalent inhibitors of urokinase and blood vessel formation |
| 07/01/2003 | US6586404 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/01/2003 | US6586403 Treating allergic reactions and inflammatory responses with tri-and dipeptides |
| 07/01/2003 | US6586402 Leucine replaced by neopentylglycine or adamantylalanine |
| 07/01/2003 | US6586401 Troponin subunit I fragment and homologs thereof |
| 07/01/2003 | US6586400 Human therapeutic uses of BPI protein products |
| 07/01/2003 | US6586399 Drug delivery of glucagon-like peptides to treat Crohn*s disease and inflammatory bowel disease |
| 07/01/2003 | US6586398 Chemically modified novel erythropoietin stimulating protein compositions and methods |
| 07/01/2003 | US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization |
| 07/01/2003 | US6586396 Subcutaneous administration of natriuretic peptide |
| 07/01/2003 | US6586395 Apoptosis-modulating proteins |
| 07/01/2003 | US6586394 Tissue-derived tumor growth inhibitor |
| 07/01/2003 | US6586393 Cyclic peptide antibiotics from Actinomadura sp. of given formula; selective inhibitory activity against E. coli RNA polymerase; use treating infections |
| 07/01/2003 | US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 07/01/2003 | US6586391 Method of ameliorating erectile dysfunction |
| 07/01/2003 | US6586390 Diagnostics, forensics, genetic mapping |
| 07/01/2003 | US6586389 Cubilin protein, DNA sequences encoding cubilin and uses thereof |
| 07/01/2003 | US6586388 Method of using recombinant osteogenic protein to repair bone or cartilage defects |
| 07/01/2003 | US6586245 Antisense modulation of CD40 ligand expression |
| 07/01/2003 | US6586244 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 |
| 07/01/2003 | US6586243 Producing a disease-specific immunogenic cell by isolating CD34 negative hematopoietic stem cells, incubating in culture medium with colony stimulating factor, and interleukin-4 to develop into programmable antigen presenting cells (pAPC's) |
| 07/01/2003 | US6586242 TAO protein kinases and methods of use therefor |
| 07/01/2003 | US6586225 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging |
| 07/01/2003 | US6586222 Recombinant PR-3 and compositions thereof |
| 07/01/2003 | US6586206 Methods for making recombinant proteins using apoptosis inhibitors |
| 07/01/2003 | US6586205 43239 a novel GPCR-like molecule and uses thereof |
| 07/01/2003 | US6586203 ARF-P19, a novel regulator of the mammalian cell cycle |
| 07/01/2003 | US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a |
| 07/01/2003 | US6586185 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 07/01/2003 | US6586182 Selecting amino acid sequence variations based on computer modeling; polynucleotides comprising subsequences of nucleic acids encoding the amino acid variations; reassembling into nucleotide sequences encoding mutagenized polypeptides |
| 07/01/2003 | US6586179 Human Eag2 |
| 07/01/2003 | US6586174 Detecting CD8+ by contacting with culture of cells that contain recombinant DNA expression vector in which a reporter gene is associated with promoter sequence; measuring inhibition of reporter gene; can use in drugs for AIDS |
| 07/01/2003 | US6586011 For therapy of thrombotic condition and reducing the time required for reperfusion of an occluded blood vessel |
| 07/01/2003 | US6586003 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/01/2003 | US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 07/01/2003 | US6585995 Administering to a subject to inhibit a vaso-occlusive event an agent that reduces platelet counts in the subject in an amount effective to reduce platelet count in the subject to at least a low normal level |
| 07/01/2003 | US6585993 Controlled release neurotoxin system |
| 07/01/2003 | US6585982 Treatment of infertility |
| 07/01/2003 | US6585971 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof |